Impact of the use of proton pump inhibitors on pembrolizumab effectiveness for advanced urothelial carcinoma
…, Y Nagata, R Kimuro, K Higashijima… - Anticancer …, 2022 - ar.iiarjournals.org
Background/Aim: This study aimed to clarify the impact of proton pump inhibitors (PPIs) on
oncological outcomes in patients who received pembrolizumab for advanced urothelial …
oncological outcomes in patients who received pembrolizumab for advanced urothelial …
Efficacy and tolerability of enfortumab vedotin for metastatic urothelial carcinoma: Early experience in the real world
…, K Jojima, M Harada, K Higashijima… - Anticancer …, 2023 - ar.iiarjournals.org
Background/Aim: This study retrospectively investigated the impact of enfortumab vedotin (EV)
monotherapy on the oncological outcome, safety profile, and health-related quality of life (…
monotherapy on the oncological outcome, safety profile, and health-related quality of life (…
Efficacy of platinum-based chemotherapy in patients with metastatic urothelial carcinoma with variant histology
…, K Murooka, Y Okumura, T Takaba, K Higashijima… - In Vivo, 2024 - iv.iiarjournals.org
Background/Aim: Variant urothelial carcinoma (VUC, defined herein as urothelial carcinoma
with any histological variant) is frequently observed at an advanced stage. However, the …
with any histological variant) is frequently observed at an advanced stage. However, the …
[HTML][HTML] Evaluation of the extent of variant histology in urothelial carcinoma as a predictive marker of clinical outcomes after radical cystectomy
…, H Noguchi, R Moriya, K Higashijima… - Cancer Diagnosis & …, 2021 - ncbi.nlm.nih.gov
Results We identified 103 and 47 patients with pure urothelial carcinoma (UC) and a VH in
UC, respectively. At the cutoff of 80%, univariate analysis identified significant differences in …
UC, respectively. At the cutoff of 80%, univariate analysis identified significant differences in …
Real-world treatment outcomes of patients with penile cancer in the Kyushu–Okinawa area of Japan in the pre-guideline era
T Yamaguchi, M Goya, K Higashijima… - Japanese journal of …, 2023 - academic.oup.com
Objectives To understand the real-world outcomes for patients with penile cancer in the
Kyushu–Okinawa area before the introduction of practice guidelines in Japan. Methods We …
Kyushu–Okinawa area before the introduction of practice guidelines in Japan. Methods We …
Oncological Outcome After Radical Prostatectomy without Pelvic Lymph Node Dissection for Localized Prostate Cancer: Follow-up Results in a Single Institution
I Tomisaki, H Ikuta, K Higashijima, R Onishi… - Cancer …, 2019 - Taylor & Francis
The oncological benefit of pelvic lymph node dissection (PLND) is still debatable because
data on clinical outcomes of radical prostatectomy (RP) without PLND are lacking. In this study…
data on clinical outcomes of radical prostatectomy (RP) without PLND are lacking. In this study…
Clinical impact of C-reactive protein flare response in patients with advanced urothelial carcinoma who received pembrolizumab.
I Tomisaki, M Harada, A Minato, K Higashijima… - 2024 - ascopubs.org
634 Background: C-reactive protein (CRP) has been reported as one of the useful predictive
markers in patients with advanced urothelial carcinoma (UC). Not only baseline revel, …
markers in patients with advanced urothelial carcinoma (UC). Not only baseline revel, …
Avelumab or pembrolizumab: Which is the better subsequent treatment in patients with advanced urothelial carcinoma who did not show progression after 4 cycles of …
I Tomisaki, M Harada, A Minato, K Higashijima… - 2024 - ascopubs.org
633 Background: In platinum eligible patients with advanced urothelial carcinoma (UC),
there are two treatment options if they did not show progression after 4 cycles of first line …
there are two treatment options if they did not show progression after 4 cycles of first line …
Oncological outcome of intraarterial chemotherapy combined with radiotherapy compared to radical cystectomy for patients with muscle invasive bladder cancer.
K Higashijima, I Tomisaki, A Minato, K Harada… - 2023 - ascopubs.org
515 Background: Although radical cystectomy (RC) has been a standard treatment for
muscle invasive bladder cancer (MIBC), some patients are unfit or refuse RC. Intraarterial …
muscle invasive bladder cancer (MIBC), some patients are unfit or refuse RC. Intraarterial …
Clinical Statistics From 2017 to 2019 in the Department of Urology, Hospital of the University of the Occupational and Environmental Health, Japan
…, G Yamasaki, K Iwakuma, K Higashijima… - Journal of …, 2022 - europepmc.org
We introduced the da Vinci Xi surgical system (Intuitive Surgical GK CA) in January 2018, and
here we report clinical statistics on outpatients, inpatients, and surgical procedures for the …
here we report clinical statistics on outpatients, inpatients, and surgical procedures for the …